Spike Health
Release time:
2020-08-14
Jianfeng Health
Jianfeng Group has entered the big health industry with 20 years of pharmaceutical enterprise details and established Jianfeng Health Technology Company. At present, it has formed three major business sectors: health care products, plant extracts and Chinese herbal pieces. More than 30 products such as "Sunimei" series of health care products, "Renshou Tang" brand fine Chinese herbal pieces, cranberry, ginkgo leaf and other plant extracts have been put on the market. In the future, Jianfeng Health will take digitally controlled plant extraction, production and processing of Chinese herbal pieces, dietary supplements and health food production as its main development direction, and become a well-known health industry enterprise with core competitiveness.
Build Big Health Industry
2012 9 7 , Zhejiang Jianfeng Biotechnology Co., Ltd. was officially registered and established, marking a solid step forward for Jianfeng Group to big health industry. In fact, Jianfeng Group's big health industry has been quietly laid out and carefully reserved. As early as the beginning of 2010 , Jianfeng Pharmaceutical started the construction of health care products factory buildings, the introduction of production lines, product research and development, etc. In 2012 , the two production lines of soft and hard capsules in the health care product workshop obtained the production license, which meant that the health food that had obtained the production document number at that time could be officially produced and sold.
In 2014 , Zhejiang Jianfeng Biotechnology Co., Ltd. was officially renamed as Zhejiang Jianfeng Health Technology Co., Ltd., and related businesses under the Group were also adjusted accordingly to form a peak health product segment with Jianfeng Health Technology Co., Ltd. as the core. At the same time, in order to develop a large health industry, Jianfeng Health has built a new Chinese herbal medicine workshop and an automated plant extraction workshop on the basis of the original health food production conditions. The newly-built production line of Chinese herbal pieces has an annual output of ,1200 tons, which is more than double the production capacity of the original herbal pieces factory. It obtained the drug GMP certificate on , 2015 , , 11, , , 18, . At the same time, the new production line has also carried out technical transformation according to the standards of the new pharmacopoeia. According to the production process requirements of broken Ganoderma lucidum spore powder and other direct oral decoction pieces, a high-standard direct oral decoction pieces clean workshop has been built. Most of the testing items of Chinese herbal pieces can be tested by themselves, greatly reducing the batch of third-party testing. At the end of 2015 , the newly-built automated plant extraction workshop of Jianfeng Health also successfully passed the expert review of GMP , obtained the production license of plant extraction health food, and was officially put into production in January of 2016 . The whole process of automatic extraction and production is controlled by the central computer, and the production status is monitored in real time. At present, it can meet the production requirements of most plant extracts and occupy the leading level in the same industry. Spike Health also successfully declared as the second batch of "machine substitution" pilot enterprises in Jinhua City with this project as the main body.
Improve the Product Market Pattern
In the autumn of 2012 , at the China Pharmaceutical Retail Industry Information Conference and the China-Business Cooperation and Development Dialogue Celebration held in Sanya, Hainan, Jianfeng solemnly introduced the three products of "Grape Seed Extract Soft Capsule", "Gutai Capsule" and "Goodnight Soft Capsule" to more than ,400 mainstream retail chain enterprises, this is the first public appearance of peak health care products, and high-profile announcement that peak will enter the big health industry with the business philosophy of "green, natural and healthy. 2013# At the beginning of 53 years, it integrated the technical ability of producing grape seed extract for more than ten years, and the first product of "Sunimei" grape seed extract soft capsule, which entered the big health industry, went on the market smoothly; Gutai capsule and Goodnight soft capsule also passed the on-site certification and product quality inspection of the provincial bureau, and reported to the national bureau to wait for the approval of the production document number... The development and production of health products are progressing steadily.
Peak Health is based on the concept of "refined ancient prescription, changing tradition into fashion; Prevention before disease occurs, re-conditioning and health protection". Through modern technology, traditional Chinese medicine can retain sufficient activity and effective ingredients, thus significantly improving the curative effect, optimizing the form of ordinary food, and treating "disease without disease" by diet therapy ". From the health care products industry has gradually developed into the main health food (including functional food), plant extracts, fine Chinese herbal medicine and Chinese herbal pieces of three major product series.
Peak Health Food has GMP production lines for soft capsules and hard capsules , which also covers the production of solid beverages, plant liquid beverages, soft candies and teabags. At present, the domestic health care product market is fiercely competitive. With the continuous increase of the state's supervision of health care products and the gradual change of consumers' consumption concept, Jianfeng Health combines the comprehensive advantages of enterprises, adjusts marketing ideas in a timely manner, and attracts investment around the exclusive sales channel line. Investment promotion is carried out through exhibitions, network platforms, media and other ways, and participates in more than 10 exhibitions every year. With the new retail promotion model as the core to carry out e-commerce work, through self-media, cross-industry alliances, free sharing experience and other online and offline promotion forms to carry out the drainage work of target customers, to take high-frequency offline salons, training, wind direction, lectures and other forms to carry out hierarchical distribution. In order to expand new retail channels, this year's peak health also specifically for women's health, anti-aging, qi and blood, gastrointestinal conditioning, menstrual adjustment and other aspects, independent research and development of suitable for women's plant medicine Suniwei brand series of solid drinks Fuyan drink, Liangyan drink, Qi Yuan drink, Wei filter drink, Yue Chang drink and other products. The terminal market is built through the model of Zhejiang model market, and through the promotion forms such as platform investment promotion and customer referral, the local and municipal markets are copied in stages, and the parallel mode of self-management of some local markets and distribution agents of some local markets is implemented to continuously expand the market.
plant extract adopts advanced intelligent automatic extraction production line, giving full play to the rich theoretical and practical experience accumulated over the years. Now there are mainly cranberry, rose rhodiola, ginkgo leaf, cinnamon, mulberry leaf, wolfberry, Pueraria lobata and other plant extract products. Jianfeng Health will take the marketing idea of "tree superior varieties and strong brand effect", take cranberry extract as the first brand product marketing to enhance the overall sales influence of plant extract, establish the import and domestic stable procurement channels of Rhodiola rosea extract, give full play to the existing brand effect of Ginkgo biloba extract, seek the way of differentiated production and sales of products, continuously optimize the production process of wolfberry, cinnamon, mulberry leaf and other potential varieties, and reduce production costs, gradually cultivate market sales.
Fine Chinese Medicinal Materials and Chinese Herbal Pieces Plate adopts the century-old brand "Renshou Tang" to carry out brand unification strategy, focusing on and leading the research and development of Zhejiang genuine medicinal materials "Zhejiang eight flavors. In the future, we will integrate the favorable resources of ordinary Chinese medicine tablets, gradually cultivate self-employed key core varieties, promote the construction of commercial and industrial channels, and improve the ability to generate profits. In 2015 , Jianfeng Health hosted the 9th Forum on Innovation and Development of Chinese Herbal Pieces and the Symposium on International Business Standards of Chinese Herbal Pieces. Nearly 100 representatives of relevant industry leaders, well-known experts and entrepreneurs in the field of Chinese herbal pieces jointly sought the development plan of Chinese herbal pieces industry at the meeting, further clarifying the future development direction of innovative herbal pieces. This forum is the first time that Jianfeng Health has hosted a national academic seminar on decoction pieces, allowing experts and entrepreneurs in the industry to fully understand the product quality, production technology, and technical level of Jianfeng Health, which will help the future development of the Jianfeng Health industry.
2016 6 July 3 , the peak health experience hall, which is the image window for peak health to display and expand its business, officially opened to welcome guests and is divided into two parts: the product display center and the experience hall. The exhibition center displayed the "Shunimei" series of health products and the "Renshou Hall" brand innovative products. The hall also has an electronic screen. The hall also broadcasts the health series "Healthy Woman Flower", which is shot in the form of interviews to promote scientific and healthy lifestyle, diet, health care and other knowledge from many sides.
In addition, in order to further improve brand awareness and repay the society, in recent years, Jianfeng Health has also jointly launched a series of activities such as the Dragon Boat Festival zongzi competition, the national walking, and the free clinic community tour in conjunction with Jinhua TV Station and Yi Jiantang. It has participated in the free clinic activities of respecting and loving the elderly, provided free testing services such as bone mineral density testing for the general public, publicized and introduced various health concepts and health care knowledge, changing tradition into fashion; Preventing disease before disease, re-conditioning and health "smart and healthy lifestyle. At the same time, in the process of advocating a healthy lifestyle and improving the health awareness of the whole people, brand communication is integrated to let the citizens further understand the product-related knowledge and achieve the purpose of publicity.
Pay attention to product research and development technology
Since its establishment, Jianfeng Health has attached great importance to the training of scientific and technological personnel, paid attention to product research and development and the protection of intellectual property rights, and encouraged employees to invent and create. It is an agricultural science and technology enterprise in Zhejiang Province, Zhejiang Science and Technology Research and Development Center, and Jinhua High-tech Enterprise. In recent years, Jianfeng Health has established long-term cooperative relations of scientific research and development and achievement transformation with China Pharmaceutical University, Shenyang Pharmaceutical University, Jiangnan University and other well-known domestic universities. It is the postgraduate practice education base of Shenyang Pharmaceutical University and Zhejiang Gongshang University. The R & D center is equipped with a number of advanced R & D and testing equipment such as high performance liquid chromatography, supercritical extraction, freeze drying, etc. At present, it has obtained authorized invention patents 3 , design patents 6 , and invention patents 8 under examination.
Peak Health Quality Management and Testing 80% of the personnel above have bachelor's degree or above. The infrastructure, personnel, hardware and software of the testing center are configured according to the requirements of drug production management standards, reaching the quality management level of GMP . At the same time, Jianfeng Health also cooperates with third-party testing institutions such as Jinhua Food and Drug Research Institute, SGS , Continental Analysis, and Penetrine Testing to effectively monitor and control pesticide residues, heavy metals and other indicators to ensure the green, natural, healthy and safe products.
In the future, Jianfeng Health will also actively play the role of the provincial agricultural science and technology research and development center platform, establish an innovation system suitable for enterprise development, strengthen the intermediate link of the transformation of scientific and technological achievements into productivity, and form and gradually improve the enterprise as the main body. Relying on the scientific research institutes of universities, a scientific and technological innovation system combining independent innovation with introduction and digestion.
health products is a booming industry, and the peak entered this industry precisely because it saw broad prospects for development. The big health industry is facing the task of expanding quantity, improving quality and moving towards an upgraded version. It will continue to focus on the growing health care needs of the people, and continue to improve the concept of big health, big health education, big health technology, big health industry, big health services, etc. System, build a big health industry with reasonable structure, high technology content, strong competitiveness, and meet the needs of the people, promote the traditional single treatment model to the new model of "prevention-treatment-maintenance-management" integration. Jianfeng Health has passed many quality standard system certifications such as GMP , IS09001 , IS022000 , HALAL , KOUSHER , etc. With profound technical accumulation and business experience, excellent talent team and management system, Jianfeng is full of confidence and expectation in this industry. It is believed that in the near future, Jianfeng Health Technology Company will move forward "healthily" and become a well-known health industry enterprise with core competitiveness.
More information
Two Cement Enterprises Prosperous Production and Sales in May
With the gradual easing of the new crown epidemic, all over the project has started, Hubei, Yunnan two provinces cement market continued to improve, Daye peak cement company, Yunnan peak cement company two enterprises have recently shown a good momentum of production and sales. In May, the sales volume of Yunnan Jianfeng cement continued to rise. As of the time of publication, the average daily shipment volume reached more than 7400 tons, and the highest daily shipment volume reached more than 8700 tons, and the production capacity was fully released. Over the past few days, Yunnan Peak Packaging System has made great efforts to overcome the impact of narrow distribution sites and many cement varieties to ensure the completion of delivery tasks with good quality and quantity every day. In order to further balance production and sales and create conditions for the homogenization of cement delivered from the factory, Yunnan peak packaging system puts forward work requirements for relevant posts, emphasizes equipment inspection and process inspection during production, strictly implements safety operation procedures, and maintains safe and efficient operation of the system. Due to the impact of the new crown epidemic, Hubei cement market started late, Wuhan market is the hardest hit area, the current project construction is still not fully started, the volume pressure is greater. For this reason, daye peak departments cooperate closely, increase market development efforts, develop new mixing stations, focus on increasing the bulk share of Xianning, Huanggang and Wuhan markets, seize the opportunity of fine weather, and achieve the goal of rapid output. Internally, on the basis of equipment technical renovation and production capacity improvement, the delivery is effectively guaranteed, and the daily delivery capacity can basically be maintained at 10,000 tons. In May, Daye Peak sold more than 300000 tons of cement, an increase of 20% over the same period last year, with an average daily sales volume of more than 9900 tons, the highest in the current period since Daye Peak was put into production.
2020
07-31
The company's "safe production month" activities are about to start
June 2020 is the 19th national "safe production month", the theme of the activity is "eliminating hidden dangers of accidents and building a strong line of defense". A few days ago, the group company issued a notice to arrange the activities related to the organization of "safe production month" and put forward requirements. According to the group's "safe production month" activity plan, different key thematic activities will be held in the four weeks of June. The first week is the "Publicity and Safety Education Week", which focuses on the use of WeChat groups, electronic screens, publicity boards, banners, slogans and other forms for safety publicity, and organizes the study of national safety regulations, company safety system specifications and accident-free factory creation standards, Organize to watch safety warning education films, learn accident cases, etc., and improve employees' safety awareness by creating a safety atmosphere and organizing learning activities. The focus of the activities in the second week is "looking for potential sources of danger around you". Each unit takes departments and teams as units to investigate and analyze the potential risk factors in the process of daily production, maintenance and operation, find out the hazard sources that have not been included in the scope of risk point control, and report to the safety management department of the unit to form a risk assessment report, put forward solutions or suggestions, and supervise the implementation of rectification and timely eliminate potential safety hazards. The third week is the "on-site safety innovation achievements exhibition week", which focuses on the achievements of each unit in on-site safety management and on-site safety facilities in the past year, which are displayed in the form of pictures and texts through beautiful articles and wechat, so as to learn from each other and promote common progress. The fourth week is the "safety training and drill week", and the group company organizes the standardization of safety production and the elimination of hidden dangers.
2020
07-31
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-31
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-30
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-22
On April 24, Jiang Xiaomeng, chairman of the group company, presided over the 14th meeting of the 10th board of directors of the company, and deliberated and passed 14 related reports and motions such as the 2019 annual board of directors report, the 2019 general manager business report and the 2019 annual report. The general manager's report pointed out that 2019 is the first year of the implementation of the group's new five-year strategic development plan (2019-2023) and the new three-year business plan (2019-2021) for each business sector. the management team has carried out various operation and management work in an orderly manner around the general policy of "innovation and reform, integration and promotion, scientific layout and steady development", and has better completed the business objectives set by the board of directors at the beginning of the year. In the whole year, the company achieved a total operating income of 3.548 billion billion yuan, an increase of 5.51 percent over the same period last year; net profit attributable to shareholders was 0.725 billion billion yuan, with earnings per share reaching 2.11 billion yuan, an increase of 23.14 percent over the same period last year, a record high; total assets at the end of the year were 5.475 billion billion yuan, an increase of 11.71 percent over the same period last year; and net assets attributable to shareholders were 3.789 billion billion yuan, an increase of 19.81 percent. During the reporting period, the company's two main businesses have achieved great development, benefiting from the further promotion of supply-side structural reform, the overall operation of the cement industry in 2019 is stable, and the industry benefits are further improved. During the reporting period, the company made new progress in the construction of cement projects, completed the acquisition, capital increase and name change of Guizhou Mingchuan (Guizhou Huangping Jianfeng Cement Co., Ltd.), and continued to invest in the construction of its new dry cement production line with a daily output of 4500 tons of clinker.
2020
07-31